Manal Ali almalki

Dr. Manal Ali almalki


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Acta Informatica Medica
Verified
Journal Article
Open access
MAManal Ali almalki
Manal Ali almalki
FAFahad Azeez
Fahad Azeez
Health chatbots are rising in popularity and capability for fighting the novel SARS-CoV-2 coronavirus (COVID-19). This study aims to review the current literature on COVID-19 related chatbots in healthcare, identify and characterize these emerging technologies and their applications for combating COVID-19, and describe related challenges. The authors conducted a scoping review of peer-reviewed literature on COVID-19, guided by the Arksey and O’Malley framework. PubMed/MEDLINE and Google Scholar were searched over a period between January and September 2020 by using the keywords “COVID* chatbot”, “virtual assistant”, “AI enabled platform COVID” and associated synonyms. Relevant studies’ references were checked for further articles. The content of these studies was screened and thematically analyzed by the two authors. Out of 543 articles initially identified, 9 were eligible for inclusion. Studies describing chatbots’ development and architecture (n=6) were the most common, and only 3 empirical studies on the user experience were identified. Our scoping review identified five key applications of the current health chatbots, which were: disseminating health information and knowledge; self-triage and personal risk assessment; monitoring exposure and notifications; tracking COVID-19 symptoms and health aspects; and combating misinformation and fake news. Furthermore, these technologies can accomplish the following tasks: ask and answer questions; create health records and history of use; complete forms and generate reports; and take simple actions. Nonetheless, the use of health chatbots poses many challenges both at the level of the social system (i.e., consumers’ acceptability) as well as the technical system (i.e., design and usability). Using health chatbots to combat COVID-19 is a practice still in its infancy. We believe that our work will help researchers in this domain gain better understanding of this novel technology’s design and applications, which are needed for continuous improvement in the health chatbots’ functionalities and their usefulness to fight COVID-19.

2 March 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MAManal Ali almalki
Manal Ali almalki
AGAnna Giannicchi
Anna Giannicchi
Background: Mobile phone apps have been leveraged to combat the spread of COVID-19. However, little is known about these technologies’ characteristics, technical features, and various applications in health care when responding to this public health crisis. The lack of understanding has led developers and governments to make poor choices about apps’ designs, which resulted in creating less useful apps that are overall less appealing to consumers due to their technical flaws. Objective: This review aims to identify, analyze, and categorize health apps related to COVID-19 that are currently available for consumers in app stores; in particular, it focuses on exploring their key technical features and classifying the purposes that these apps were designed to serve. Methods: A review of health apps was conducted using the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. The Apple Store and Google Play were searched between April 20 and September 11, 2020. An app was included if it was dedicated for this disease and was listed under the health and medical categories in these app stores. The descriptions of these apps were extracted from the apps’ web pages and thematically analyzed via open coding to identify both their key technical features and overall purpose. The characteristics of the included apps were summarized and presented with descriptive statistics. Results: Of the 298 health apps that were initially retrieved, 115 met the inclusion criteria. A total of 29 technical features were found in our sample of apps, which were then categorized into five key purposes of apps related to COVID-19. A total of 77 (67%) apps were developed by governments or national authorities and for the purpose of promoting users to track their personal health (9/29, 31%). Other purposes included raising awareness on how to combat COVID-19 (8/29, 27%), managing exposure to COVID-19 (6/29, 20%), monitoring health by health care professionals (5/29, 17%), and conducting research studies (1/29, 3.5%). Conclusions: This study provides an overview and taxonomy of the health apps currently available in the market to combat COVID-19 based on their differences in basic technical features and purpose. As most of the apps were provided by governments or national authorities, it indicates the essential role these apps have as tools in public health crisis management. By involving most of the population in self-tracking their personal health and providing them with the technology to self-assess, the role of these apps is deemed to be a key driver for a participatory approach to curtail the spread of COVID-19. Further effort is required from researchers to evaluate these apps’ effectiveness and from governmental organizations to increase public awareness of these digital solutions.

30 July 2024 in Multimedia Tools and Applications
Verified
Journal Article
Open access
PDF file
NANawaf Alharbe
Nawaf Alharbe
MAManal Ali almalki
Manal Ali almalki
Deep learning and the Internet of Things (IoT) are revolutionizing the healthcare industry. This study explores the potential commercial transformation resulting from IoT-enabled healthcare systems that use deep learning for patient monitoring and diagnosis. Wearables, smart sensors, and internet-connected medical devices allow doctors to monitor patients' vital signs, activities, and physiological traits in real time. However, these devices generate vast and complex data, making analysis and diagnosis challenging. Deep learning models are well-suited to analyze this growing volume of medical data. Convolutional Neural Networks (CNNs) and Long Short-Term Memory (LSTM) networks can automatically recognize complex patterns and relationships in sensor data, electronic health records, and patient-reported information. This capability aids clinical professionals in diagnosing illnesses, identifying warning signs, and tailoring treatments. This paper describes a Convolutional Neural Networks (CNNs) and Long Short-Term Memory (LSTM) -based IoT-enabled healthcare system that performs feature extraction, classification, prediction, and data preparation. Additionally, it addresses interpretability issues, privacy concerns, and resource limitations of deep learning models in real-time healthcare settings. The study demonstrates the effectiveness of Convolutional Neural Networks (CNNs) and Long Short-Term Memory (LSTM) -powered IoT-based healthcare solutions, such as real-time patient monitoring, disease detection, risk prediction, and therapy optimization. These techniques can improve the quality, cost, and outcomes of healthcare. Combining Convolutional Neural Networks (CNNs) and Long Short-Term Memory (LSTM) with IoT can significantly enhance healthcare by improving disease detection, personalized treatment, and patient monitoring through connected devices and powerful analytics.

27 May 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MAManal Ali almalki
Manal Ali almalki
KGKathleen Gray
Kathleen Gray
Fernando Martin-SanchezFernando Martin-Sanchez
Fernando Martin-Sanchez
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 January 2021 in Medical Archives
Verified
Journal Article
Open access
MAManal Ali almalki
Manal Ali almalki
Consumers’ willingness to use health chatbots can eventually determine if the adoption of health chatbots will succeed in delivering healthcare services for combating COVID-19. However, little research to date has empirically explored influential factors of consumer willingness toward using these novel technologies, and the effect of individual differences in predicting this willingness. This study aims to explore (a) the influential factors of consumers’ willingness to use health chatbots related to COVID-19, (b) the effect of individual differences in predicting willingness, and (c) the likelihood of using health chatbots in the near future as well as the challenges/barriers that could hinder peoples’ motivations. An online survey was conducted which comprised of two sections. Section one measured participants’ willingness by evaluating the following six factors: performance efficacy, intrinsic motivation, anthropomorphism, social influence, facilitating conditions, and emotions. Section two included questions on demographics, the likelihood of using health chatbots in the future, and concerns that could impede such motivation. A total of 166 individuals provided complete responses. Although 40% were aware of health chatbots and only 24% had used them before, about 84% wanted to use health chatbots in the future. The strongest predictors of willingness to use health chatbots came from the intrinsic motivation factor whereas the next strongest predictors came from the performance efficacy factor. Nearly 39.5% of participants perceived health chatbots to have human-like features such as consciousness and free will, but no emotions. About 38.4% were uncertain about the ease of using health chatbots. This study contributes toward theoretically understanding factors influencing peoples’ willingness to use COVID-19-related health chatbots. The findings also show that the perception of chatbots’ benefits outweigh the challenges.

MAManal Ali almalki
Manal Ali almalki
MAMajid H Alsulami
Majid H Alsulami
AAAbdulrahman A. Alshdadi
Abdulrahman A. Alshdadi
SASaleh Naif Almuayqil
Saleh Naif Almuayqil
MAMohammed S. Alsaqer
Mohammed S. Alsaqer
Amine ChoukouAmine Choukou
Amine Choukou
Adoption of Ambient Assisted Living (AAL) technologies for geriatric healthcare is suboptimal. This study aims to present the AAL Adoption Diamond Framework, encompassing a set of key enablers/barriers as factors, and describe our approach to developing this framework. A systematic literature review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. SCOPUS, IEEE Xplore, PubMed, ProQuest, Science Direct, ACM Digital Library, SpringerLink, Wiley Online Library and grey literature were searched. Thematic analysis was performed to identify factors reported or perceived to be important for adopting AAL technologies. Of 3717 studies initially retrieved, 109 were thoroughly screened and 52 met our inclusion criteria. Nineteen unique technology adoption factors were identified. The most common factor was privacy (50%) whereas data accuracy and affordability were the least common factors (4%). The highest number of factors found per a given study was eleven whereas the average number of factors across all studies included in our sample was four (mean = 3.9). We formed an AAL technology adoption framework based on the retrieved information and named it the AAL Adoption Diamond Framework. This holistic framework was formed by organising the identified technology adoption factors into four key dimensions: Human, Technology, Business, and Organisation. To conclude, the AAL Adoption Diamond Framework is holistic in term of recognizing key factors for the adoption of AAL technologies, and novel and unmatched in term of structuring them into four overarching themes or dimensions, bringing together the individual and the systemic factors evolving around the adoption of AAL technology. This framework is useful for stakeholders (e.g., decision-makers, healthcare providers, and caregivers) to adopt and implement AAL technologies.